Review reveals critical roles of glycosylation across gut-brain signaling pathways, highlighting novel targets for glycan-based therapeutics in neurological and metabolic disorders.
The gut-brain axis is a complex bidirectional communication network linking the gastrointestinal tract and the central nervous system. Its dysregulation is closely associated with a wide range of gastrointestinal, metabolic, and neuropsychiatric disorders. Glycosylation, one of the most prevalent and structurally diverse post-translational modifications of proteins and lipids, is increasingly recognized as a regulator of multiple processes within the gut-brain axis. In this review, we summarize evidence that glycosylation influences several steps of gut-brain communication, including intestinal barrier function, microbial glycan metabolism, immune signaling, enteric and vagal pathways, blood-brain barrier integrity, and neural responses. We distinguish direct mechanistic findings from associative observations and discuss the more limited evidence for brain-to-gut regulation of intestinal glycosylation. In addition, we discuss the potential of glycosylation-targeted nutritional and microbiota-based interventions and highlight emerging opportunities to integrate glycomics with other omics approaches to dissect the complex regulatory networks underlying the gut-brain axis. In conclusion, elucidating how glycosylation shapes signaling along the gut-brain axis may open new avenues for understanding disease pathogenesis and for developing targeted therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: